Control
Semaglutide
Appetite control, sustained.
Order Inclusions
What it does for you
- /01Studied for sustained GLP-1 receptor signalling in metabolic research
- /02Examined in appetite-regulation and satiety models
- /03Used in research on glucose-dependent insulin and glucagon signalling
- /04Presented as a fixed 20mg research vial
3rd-Party Tested: 99.414%
Semaglutide Research Notes
What is Semaglutide?
Semaglutide is a long-acting analogue of glucagon-like peptide-1 (GLP-1), a signalling hormone involved in appetite, gastric emptying, insulin secretion, and glucagon regulation. Its structure was engineered to resist rapid enzymatic breakdown and remain active longer than native GLP-1.
Unlike tirzepatide, which activates GLP-1 and GIP receptors, or retatrutide, which adds glucagon-receptor activity, semaglutide acts through the GLP-1 receptor alone. This makes it an important reference compound in incretin and metabolic research.
Approved pharmaceutical semaglutide products exist for specific clinical indications. CONTROL is presented separately as a research-use-only product and is not medical treatment.
What the research shows
STEP 1 trial (Wilding et al., 2021): In 1,961 adults without diabetes, the 68-week randomized trial reported a mean body-weight change of −14.9% with once-weekly semaglutide 2.4mg versus −2.4% with placebo, alongside lifestyle intervention.
GLP-1 receptor signalling: Research links GLP-1 receptor activation with appetite and satiety signalling, glucose-dependent insulin secretion, reduced glucagon secretion, and delayed gastric emptying.
Trial safety observations: Gastrointestinal events, particularly nausea and diarrhoea, were the most frequently reported adverse effects in STEP 1 and were generally transient and mild to moderate.
Reference: Wilding J.P.H. et al. (2021). New England Journal of Medicine, 384, 989–1002. PMID: 33567185.
Ordering Semaglutide in Bali
CONTROL contains a 20mg research vial. Confirm the exact item, current availability, complete Bali delivery address, route, daily cutoff, and timing with BioPepTech before ordering.
Common Questions
Q: How does semaglutide compare with tirzepatide and retatrutide?
Semaglutide activates GLP-1 receptors. Tirzepatide activates GLP-1 and GIP receptors, while retatrutide adds glucagon-receptor activity. They are distinct research compounds and should not be treated as interchangeable.
Q: What does the 20mg vial label mean?
It identifies the total labelled compound content in the sealed vial. It is not a dosing recommendation or administration guide.
Q: How should CONTROL be stored in Bali?
Keep the sealed vial refrigerated at 2–8°C and protected from heat and direct light. Follow product and batch-specific handling instructions after reconstitution.
Q: Can it be delivered to a Bali villa or hotel?
Delivery may be possible after the team confirms the exact item, current availability, complete address, route, daily cutoff, and timing.